Everand Logo

Welcome to Everand!

  • STAT

    STAT+: Eli Lilly’s anti-vanity ad campaign for Oscars

    Eli Lilly will be unveiling a new campaign during this weekend’s Oscar awards event, with a clear message: These drugs aren’t meant to be used for cosmetic reasons. "It matters…
    by Meghana Keshavan Mar 08, 2024 1 minute
    Source: Kristoffer Tripplaar/AP

    Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

    The need-to-know this morning:

    •  said its treatment for ALS, called Relyvrio,  for patients in a large clinical

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About FDA Dithering On Pharma Patents, WHO Pandemic Talks, And More
    When it comes to a crucial controversy over patents for drug-and-device combination products, the FDA has been MIA.
    STAT1 min read
    STAT+: Element Biosciences, An Illumina Rival, On Its Genomics Ambitions — And Why It Hasn’t Gone Public
    Element Biosciences' modest growth comes at a time when some other players are struggling in a sequencer market dominated by Illumina.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
    A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.

    Related Books & Audiobooks